What Net Peptide Content Means on a Tesamorelin Listing
Net peptide content on a tesamorelin listing separates actual peptide mass from salt and moisture weight; it changes concentration math after reconstitution.
Reviewed by Yuki Tanaka, PhD, molecular biologist ·
Yuki Tanaka, PhD is a molecular biologist with a doctorate from Osaka University and postdoctoral training at Stanford School of Medicine, specializing in growth hormone axis biology, GHRH receptor signaling, and synthetic peptide analog mechanisms.
Net peptide content on a tesamorelin listing refers to the fraction of a vial’s lyophilized powder that is the actual tesamorelin peptide, as opposed to the counter-ions, residual moisture, and buffer salts that come along with it during synthesis. A vial labeled “5 mg” does not always mean 5 mg of pure tesamorelin sits inside. Depending on how the manufacturer defines that number, it can mean 5 mg of total powder, of which only a percentage is peptide.
Why lyophilized powder is not 100 percent peptide
Synthetic peptides like tesamorelin are typically produced and stored as a trifluoroacetate (TFA) or acetate salt. The counter-ion attaches to the peptide chain during purification and stays bound through lyophilization, the freeze-drying process that turns the peptide solution into powder. That counter-ion has its own mass. So does any residual water left in the cake after freeze-drying is complete.
When a lab runs amino acid analysis on a batch, it can calculate what fraction of the total dried mass is attributable to the peptide backbone itself, versus the counter-ion and moisture. That fraction is the net peptide content, usually expressed as a percentage. Reported values across commercial peptide products commonly fall somewhere in the 70 to 90 percent range, though the exact figure depends on the specific salt form and drying process a supplier uses.
Net peptide content versus HPLC purity
These two figures answer different questions, and listings sometimes present them without much explanation.
HPLC purity describes how clean the peptide is relative to other peptide-related substances. It answers the question: of the material that actually is tesamorelin-related compound, what proportion is the correctly folded, full-length target peptide versus truncated fragments, deletion sequences, or oxidized variants. A high HPLC purity number, such as 98 percent, says the peptide-related material is mostly the intended sequence.
Net peptide content answers a separate question: of everything in the vial, including non-peptide mass, what proportion is peptide at all. A vial can carry a 98 percent HPLC purity certificate and an 82 percent net peptide content figure at the same time. Both numbers can be accurate and both come from different analytical methods, typically reverse-phase HPLC for purity and amino acid analysis or nitrogen determination for net content.
Why the distinction changes the math
This matters most at the reconstitution step, when a vial’s labeled weight is used to calculate a working concentration. If a listing’s “5 mg” refers to total vial weight rather than net peptide weight, and the net peptide content is below 100 percent, then diluting as if the full 5 mg were active peptide will overstate the actual concentration.
Here is a worked example using a vial labeled 5 mg with a certificate of analysis stating 85 percent net peptide content, reconstituted with 2 mL of bacteriostatic water.
Actual peptide mass: 5 mg × 0.85 = 4.25 mg.
Concentration after reconstitution: 4.25 mg ÷ 2 mL = 2.125 mg/mL, which converts to 2,125 mcg/mL (since 1 mg = 1,000 mcg).
On a U-100 insulin syringe, where 1 mL corresponds to 100 marked units, that concentration works out to 2,125 mcg/mL ÷ 100 units/mL = 21.25 mcg per unit.
The table below compares that calculation against simply treating the label weight as 100 percent peptide.
| Basis used | Peptide mass in vial | Concentration in 2 mL | mcg per unit (U-100) |
|---|---|---|---|
| Label weight taken as net peptide (no adjustment) | 5 mg | 2.5 mg/mL | 25 mcg/unit |
| Net peptide content applied (85% COA figure) | 4.25 mg | 2.125 mg/mL | 21.25 mcg/unit |
The gap between the two rows is about 15 percent, which traces directly back to the 85 percent net content figure. Anyone recalculating concentration from a listed vial weight should confirm which basis that weight represents before doing the arithmetic. A calculator such as the one at peptcalc.com can help cross-check reconstitution math once the correct basis is known.
Where this shows up on a listing or COA
A COA that reports net peptide content will usually list it as a separate line item from HPLC purity, sometimes labeled “peptide content,” “assay,” or “net peptide (%).” Some documents state it as a range rather than a single figure. Listings that only advertise an HPLC purity percentage and say nothing about net content are not necessarily withholding information in bad faith, since not every supplier’s testing protocol generates that number, but it does mean the buyer cannot assume the labeled weight equals the peptide mass without asking.
Reputable listings for tesamorelin generally make both figures available, either directly on the product page or through a downloadable COA tied to a specific lot number. Comparing that lot-specific document against the vial in hand, rather than relying on a generic COA image reused across a product line, is the more reliable way to confirm which weight basis applies to a given batch. For buyers cross-referencing multiple sourcing options, some peer tesamorelin listing catalogs list COA availability alongside individual product entries, which makes this comparison easier to do before ordering.
Why analytical accuracy matters for research use
The distinction between peptide mass and total powder mass is not unique to commercial listings. Peer-reviewed research on growth hormone-releasing hormone analogs and related recombinant growth hormone formulations, such as a review on the rationale for recombinant human growth hormone use in HIV-associated lipodystrophy and a clinical study on recombinant human growth hormone treatment of visceral fat accumulation in HIV infection, generally report dosing in terms of active compound mass rather than total formulation weight. That convention exists because reproducibility depends on knowing exactly how much active peptide a given amount of powder represents. The same logic applies to interpreting a commercial vial’s labeled weight: total powder weight and active peptide weight are not interchangeable numbers.
Summary
Net peptide content describes what share of a lyophilized tesamorelin vial’s mass is the peptide itself, separate from counter-ion and moisture weight, and separate from HPLC purity, which measures cleanliness relative to other peptide-related material. When a listing states both figures, using the net peptide content rather than the total label weight for reconstitution math produces a concentration that better reflects what the vial actually contains.
A note on how to read this
This article is written for research and educational reference. The materials described are sold for laboratory research and are not for human consumption. Nothing here is dosing guidance, a prescription, or a clinical recommendation.